Out of BCR‐ABL negative myeloproliferative neoplasm (MPNPh−) patients, 3%–14% display a concomitant monoclonal gammopathy of unknown significance (MGUS). The gene discussed is ABL1; the disease is myeloproliferative neoplasm.